Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bickers

Showing results (261-270 of 270) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 270 results.
The Lancet. Oncology|November 14, 2016
Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trialJean Y Tang, Mina S Ally, Anita M Chanana, et al.
The Lancet. Haematology|July 3, 2025
Off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy in relapsed or refractory B-cell lymphoma: a multicentre, open-label, phase 1 studyPaolo Strati, Januario Castro, Aaron Goodman, et al.
Lancet (London, England)|January 11, 2025
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trialArmin Ghobadi, Veronika Bachanova, Krish Patel, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2010
Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and miceJean Y Tang, Michelle Aszterbaum, Mohammad Athar, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 22, 2020
Genomic profiling of late-onset basal cell carcinomas from two brothers with nevoid basal cell carcinoma syndromeO Hasan Ali, A A Yurchenko, O Pavlova, et al.
Nature Cell Biology|November 24, 2020
Haematopoietic stem cell-dependent Notch transcription is mediated by p53 through the Histone chaperone Supt16hSophia G Espanola, Hyemin Song, Eunjin Ryu, et al.
Virchows Archiv : an International Journal of Pathology|August 17, 2024
What factors influence cellular pathologists' confidence in case reporting?Harriet Evans, Peter K Kimani, Louise Hiller, et al.
Health Technology Assessment (Winchester, England)|July 14, 2025
Variation within and between digital pathology and light microscopy for the diagnosis of histopathology slides: blinded crossover comparison studyDavid Rj Snead, Ayesha S Azam, Jenny Thirlwall, et al.
Histopathology|January 17, 2024
Digital pathology for reporting histopathology samples, including cancer screening samples - definitive evidence from a multisite studyAyesha S Azam, Yee-Wah Tsang, Jenny Thirlwall, et al.
Journal of the American Academy of Dermatology|December 15, 2025
Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndromeBrian A Cahn, Runze Zhang, Allie M Sidwell, et al.
Pageof 27

Showing results (261-270 of 270) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 270 results.
The Lancet. Oncology|November 14, 2016
Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trialJean Y Tang, Mina S Ally, Anita M Chanana, et al.
The Lancet. Haematology|July 3, 2025
Off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy in relapsed or refractory B-cell lymphoma: a multicentre, open-label, phase 1 studyPaolo Strati, Januario Castro, Aaron Goodman, et al.
Lancet (London, England)|January 11, 2025
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trialArmin Ghobadi, Veronika Bachanova, Krish Patel, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2010
Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and miceJean Y Tang, Michelle Aszterbaum, Mohammad Athar, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 22, 2020
Genomic profiling of late-onset basal cell carcinomas from two brothers with nevoid basal cell carcinoma syndromeO Hasan Ali, A A Yurchenko, O Pavlova, et al.
Nature Cell Biology|November 24, 2020
Haematopoietic stem cell-dependent Notch transcription is mediated by p53 through the Histone chaperone Supt16hSophia G Espanola, Hyemin Song, Eunjin Ryu, et al.
Virchows Archiv : an International Journal of Pathology|August 17, 2024
What factors influence cellular pathologists' confidence in case reporting?Harriet Evans, Peter K Kimani, Louise Hiller, et al.
Health Technology Assessment (Winchester, England)|July 14, 2025
Variation within and between digital pathology and light microscopy for the diagnosis of histopathology slides: blinded crossover comparison studyDavid Rj Snead, Ayesha S Azam, Jenny Thirlwall, et al.
Histopathology|January 17, 2024
Digital pathology for reporting histopathology samples, including cancer screening samples - definitive evidence from a multisite studyAyesha S Azam, Yee-Wah Tsang, Jenny Thirlwall, et al.
Journal of the American Academy of Dermatology|December 15, 2025
Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndromeBrian A Cahn, Runze Zhang, Allie M Sidwell, et al.
Pageof 27